Director appointment

About this update from Surgical Innovations Group Plc

15 June 2026 Surgical Innovations Group plc ("Surgical Innovations", the "Company", or the "Group")   Director appointment   Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), announces the appointment of David Anderson as Chief Financial Officer of the Company with immediate effect.   David is an experienced board director with over 28 years' experience in senior finance roles. He is a chartered accountant and member of the Institute of Chartered Accountants of England and Wales, qualifying with Stoy Hayward (now BDO LLP). From 1998 to 2009 David was an audit partner in their London office before becoming an audit partner with Crowe Clark Whitehill (now Crowe U.K. LLP) from 2010 to 2012. Since then, David has held senior finance roles with Strategic Minerals Plc, Hakkasan Limited and CT Group International Ltd. He currently acts as the CFO and board member of LungLife AI, Inc, and as the non-board CFO and Company Secretary of Verici Dx Plc.   Under the terms of his service contract, David will act as a fractional CFO and join the Board of the Company.   Roy Davis, Chairman of Surgical Innovations said: "We are delighted to welcome David to the Company and the Board. His deep financial expertise and proven track record in listed and high growth businesses makes him an excellent addition to our team. His appointment strengthens our financial leadership as we continue to scale Surgical Innovations and capitalise on the growing demand for minimally invasive surgical solutions."   The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies:   David Mark Anderson (aged 63) is currently, or has during the past five years, been a director of the following companies:   Current directorships or partnerships Previous directorships or partnerships ·    Alithia LLP ·    LungLife AI, Inc   ·    Weston Lane Limited     Save as set out in this announcement there are no further details to be disclosed in accordance with Rule 17 and Schedule Two Paragraph (g) of the AIM Rule for Companies.   For further information please contact:   Surgical Innovations Group plc www sigroupplc com David Marsh, CEO...

View stock analysis, news, and events for Surgical Innovations Group Plc